By integrating transcriptomics of C/G-CB cells and primary C/G AML, we have identified 6 C/G-fusion-specific genes that represent potential high-value targets and validated the specific cell surface expression of FOLR1. Here, FOLR1 is linked to acute myeloid leukemia.